SOPHiA GENETICS Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	123.25	161.31	192.96	74.63	18.44
Short-Term Investments	0	17.31	72.36	22.72	0
Cash & Cash Equivalents	123.25	178.61	265.32	97.35	18.44
Cash Growth	-31.00%	-32.68%	172.56%	428.04%	-
Receivables	13.56	6.65	6.28	6.36	7.93
Inventory	6.48	5.16	5.73	3.38	3.61
Other Current Assets	4.76	5.84	5.53	2.6	3.79
Total Current Assets	148.05	196.26	282.86	109.69	33.76
Property, Plant & Equipment	23.1	21.4	15.96	5.54	6.45
Goodwill and Intangibles	27.19	19.96	15.67	13.28	10.24
Other Long-Term Assets	7.82	6.22	5.69	3.6	1.21
Total Long-Term Assets	58.11	47.58	37.32	22.42	17.9
Total Assets	206.16	243.84	320.17	132.12	51.66
Accounts Payable	5.39	6.18	6.74	5.91	5.4
Deferred Revenue	9.49	3.43	4.07	2.78	2.18
Current Debt	2.93	2.69	1.81	3.91	3.19
Other Current Liabilities	17.81	14.51	15.98	8.99	8.49
Total Current Liabilities	35.62	26.81	28.6	21.59	19.26
Long-Term Debt	15.67	14.05	11.25	3.34	5.27
Other Long-Term Liabilities	3.42	2.85	4.92	6.68	4.87
Total Long-Term Liabilities	19.09	16.9	16.17	10.02	10.15
Total Liabilities	54.71	43.71	44.77	31.61	29.4
Total Debt	18.6	16.74	13.06	7.25	8.46
Debt Growth	11.10%	28.21%	80.15%	-14.35%	-
Retained Earnings	-377.78	-298.8	-211.35	-137.68	-98.34
Shareholders' Equity	151.44	200.13	275.4	100.51	22.25
Net Cash / Debt	104.65	161.87	252.26	90.1	9.97
Net Cash / Debt Growth	-35.35%	-35.83%	179.99%	803.58%	-
Working Capital	112.43	169.45	254.25	88.11	14.5
Book Value Per Share	2.33	3.12	4.31	1.59	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).